What is the likelihood of DVT in a patient after HAPE after descending down to sea level

The likelihood of DVT after HAPE and descent to sea level is not well quantified , but available evidence suggests the main concern is not HAPE itself causing DVT after descent , rather that high altitude, dehydration, immobility, and severe illness can raise venous thromboembolism risk in general.

What the evidence suggests

High altitude is associated with thrombotic risk, and one review notes a much higher relative risk of DVT at high altitude compared with lowland settings.

In severe HAPE cases, venous thromboembolism has been reported, but this is based on selected hospitalized patients and does not mean most people with HAPE develop DVT.

CDC guidance also emphasizes that prolonged immobility increases VTE risk, which matters if the person had a long, difficult descent or was unusually inactive during illness.

Practical interpretation

For a patient who has already descended to sea level, the DVT risk depends more on individual risk factors than on the history of HAPE alone.

Higher-risk features include leg swelling or pain, recent prolonged immobility, dehydration, prior DVT/PE, clotting disorders, recent surgery, cancer, or estrogen use.

If none of those are present, the absolute risk is probably low , but not zero.

When to worry

Seek urgent medical evaluation if any of these occur:

• One-sided leg swelling, pain, warmth, or redness.
• New chest pain.
• Shortness of breath that is worse than expected after HAPE.
• Coughing blood, fainting, or a fast heart rate.

Bottom line

HAPE does not automatically imply DVT , and after descent to sea level the risk is usually driven by the person’s overall clotting risk and immobilization history, not by altitude alone.

Because PE can mimic or complicate altitude-related breathing problems, any new or worsening symptoms after HAPE deserve prompt medical review.

TL;DR: DVT after HAPE and descent is possible but not common; risk rises mainly with immobility, dehydration, and other clotting risk factors.